Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |